论文部分内容阅读
本文为探讨淋巴细胞的增加是否可作为IL-2抗肿瘤效果的指标进行了下列试验。著者对8例患者施以IL-2疗法。其中多发性骨髓瘤3例、红白血病及以皮肤损害为主的恶性淋巴瘤各1例、乳癌及结肠癌肝转移各1例、肺癌且脾和肾上腺转移1例。著者用IBM2997血液成分分离装置自患者未梢血液单核细胞层分离淋巴细胞,制
This article to explore whether the increase in lymphocytes can be used as IL-2 anti-tumor effect of the following tests. The authors administered 8 patients with IL-2 therapy. One case of multiple myeloma, erythroleukemia and skin lesions mainly one case of malignant lymphoma, one case of breast cancer and colon cancer liver metastases, lung cancer and spleen and adrenal metastasis in 1 case. Author IBM2997 blood component separation device from the patient’s peripheral blood mononuclear cell layer separation of lymphocytes,